Home
Conditions
Bacterial Infections and Mycoses

Clinical trial condition

Bacterial Infections and Mycoses

Explore clinical trials studying Bacterial Infections and Mycoses. Study availability and eligibility vary by location and protocol.

5,905 public trials 636 recruiting studies

Refine in advanced search Browse all conditions

Bacterial Infections and Mycoses trial results

Completed

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age

NCT00808444

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations: GSK Investigational Site Kuala Lumpur, Malaysia

GSK Investigational Site Seremban, Negeri Sembilan, Malaysia

GSK Investigational Site Singapore

GSK Investigational Site Singapore

View Trial Details

Completed

US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

NCT00282295

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +12 more
Locations: GSK Investigational Site Chandler, Arizona, United States

GSK Investigational Site Little Rock, Arkansas, United States

GSK Investigational Site Fountain Valley, California, United States

GSK Investigational Site Golden, Colorado, United States

View all 24 locations

View Trial Details

Completed

Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.

NCT00829010

Conditions: Acquired Immunodeficiency Syndrome, Bacterial Infections, Bacterial Infections and Mycoses, +19 more
Locations: GSK Investigational Site Soweto, Gauteng, South Africa

View Trial Details

Completed

Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children

NCT01245049

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations: GSK Investigational Site St Austell, Cornwall, United Kingdom

GSK Investigational Site Southampton, Hampshire, United Kingdom

GSK Investigational Site Axbridge, Somerset, United Kingdom

GSK Investigational Site Taunton, Somerset, United Kingdom

View all 13 locations

View Trial Details

Completed

T2Bacteria Panel Pivotal Study

NCT02535468

Conditions: Bacteremia, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations: Henry Ford Health System Detroit, Michigan, United States

University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States

Rhode Island Hospital Providence, Rhode Island, United States

View Trial Details

Completed

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents

NCT00950612

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +4 more
Locations: GSK Investigational Site Worcester, Western Province, South Africa

View Trial Details

Completed

Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment

NCT00182429

Conditions: Antibiotic-associated Diarrhea, Bacterial Infections, Bacterial Infections and Mycoses, +13 more
Locations: Hamilton General Hospital Hamilton, Ontario, Canada

McMaster University Medical Centre Hamilton, Ontario, Canada

St. Joseph's Healthcare Hamilton, Ontario, Canada

Henderson General Hospital Hamilton, Ontario, Canada

View Trial Details

Completed

Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

NCT00317135

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

View Trial Details

Completed

Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

NCT00317187

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site Bangkok, Thailand

View Trial Details

Completed

Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH

NCT02390232

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Digestive System Diseases, +8 more
Locations: CHU Toulouse Toulouse, France

View Trial Details

Bacterial Infections and Mycoses

Bacterial Infections and Mycoses trial results

Related conditions